Ignite Creation Date:
2024-05-06 @ 7:33 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06054906
Status:
RECRUITING
Last Update Posted:
2023-09-26
First Post:
2023-09-12
Brief Title:
Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy PLOF for Resectable Locally Advanced Gastric Cancer
Sponsor:
Huashan Hospital
Organization:
Huashan Hospital
Organization Data
Organization:
Huashan Hospital
Class:
OTHER
Study ID:
KY2022-1018
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Huashan Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhongguang Luo MD
Responsible Party Title:
Chief Physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Huashan Hospital
Old Name:
None
Old Organization:
None